Anti-IL5 therapy significantly reduces moderate and severe exacerbations in asthma and COPD, preventing major ...

Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...

Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...

For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to the intensive care unit ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic phenotype. Some 20% to 40% of COPD patients have elevated blood eosinophil counts ...

Adding mepolizumab to inhaled triple therapy significantly improved exacerbation outcomes compared with placebo in adults with chronic obstructive pulmonary disease (COPD), based on data from the ...

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage to the airways. It typically refers to emphysema and chronic bronchitis.

SAN DIEGO -- The beta-blocker bisoprolol did not improve exacerbations in chronic obstructive pulmonary disease (COPD) patients, a randomized clinical trial found. Exacerbations requiring antibiotics, ...

About The Study: Among people with chronic obstructive pulmonary disease (COPD) at high risk of exacerbation, treatment with the β1-selective β-blocker bisoprolol did not reduce the number of ...

November marks COPD Awareness Month, and advocates this year will focus on action, and education about chronic obstructive ...

“I live with COPD, and I have experienced the emotional and physical toll it takes. Sadly, the status quo is unacceptable. We sorely need improved and new therapeutic approaches that will enable us to ...

March 18, 2010 — Pharmacotherapy, ventilation strategies, and other management issues regarding chronic obstructive pulmonary disease (COPD) exacerbations are reviewed in an article published in the ...